Summary
Transcriptome prediction methods such as PrediXcan and FUSION have become popular in complex trait mapping. Most transcriptome prediction models have been trained in European populations using methods that make parametric linear assumptions like the elastic net (EN). To potentially further optimize imputation performance of gene expression across global populations, we built transcriptome prediction models using both linear and non-linear machine learning (ML) algorithms and evaluated their performance in comparison to EN. We trained models using genotype and blood monocyte transcriptome data from the Multi-Ethnic Study of Atherosclerosis (MESA) comprising individuals of African, Hispanic, and European ancestries and tested them using genotype and whole-blood transcriptome data from the Modeling the Epidemiology Transition Study (METS) comprising individuals of African ancestries. We show that the prediction performance is highest when the training and the testing population share similar ancestries regardless of the prediction algorithm used. While EN generally outperformed random forest (RF), support vector regression (SVR), and K nearest neighbor (KNN), we found that RF outperformed EN for some genes, particularly between disparate ancestries, suggesting potential robustness and reduced variability of RF imputation performance across global populations. When applied to a high-density lipoprotein (HDL) phenotype, we show including RF prediction models in PrediXcan revealed potential gene associations missed by EN models. Therefore, by integrating other ML modeling into PrediXcan and diversifying our training populations to include more global ancestries, we may uncover new genes associated with complex traits.
Introduction
Advancements in high-throughput genotyping and sequencing technologies have led to an explosion in the amount of genetic data publicly available.1 Leveraging these technological successes, genome-wide association studies (GWASs) have continued to uncover thousands of genetic variants that are associated with different complex traits in humans.2 However, most of these variants identified through GWAS are usually found in the noncoding region of the genome, thereby complicating identification of their functional importance in understanding the biology of complex traits.1–4 Many studies have shown that these regions are particularly enriched for gene regulatory variants such as expression quantitative loci (eQTLs), and thus genetically regulated gene expression might play a critical role in explaining the phenotypic variability in a wide range of complex traits.5–9 More so, given that a handful of SNPs have large effect associations that can explain most of the heritable component of gene expression traits, mathematical modeling of the relationship between genotype and gene expression is achievable using moderate sample sizes.10 Indeed, this has led to the development of transcriptome methods such as PrediXcan11 and FUSION,12 which integrate cis-eQTL genotype and transcriptome datasets in order to predict the transcriptome from GWAS data and subsequently test for association between the predicted transcriptome and trait of interest. Unlike traditional GWASs, these gene-based approaches combine multiple SNPs into one functional unit and point directly to a biological mechanism, that is, either increased or decreased expression of a particular gene is associated with a trait. Because most GWASs lack corresponding transcriptome data, these methods may identify gene regulatory mechanisms underlying complex traits.
More specifically, the mathematical model used in PrediXcan is elastic net (EN),13 while FUSION uses Bayesian sparse linear mixed model (BSLMM).14 The EN model used by PrediXcan is a combination of L1 (LASSO)15 and L2 (Ridge)16 regularization of the cis-eQTL effect sizes, thus assuming a parametric prior for the cis-eQTLs. The same parametric assumption is made by FUSION, since BSLMM assumes a normal mixture prior, combining Bayesian variable selection regression (BVSR)17 and linear mixed modeling (LMM).18 Given their parametric and linear assumptions, these tools fail to flexibly model the distributions of the genotypes and their relationship with gene expression.19 Some SNP and measured gene expression relationships can be best modeled mathematically with non-linear and non-parametric assumptions.19,20 Manor and Segal20 showed that by using simple non-linear modeling with the K nearest neighbor (KNN)21 algorithm, robust gene expression prediction can be achieved using just cis-eQTLs. Wang et al.22 found that a mixed model-based random forest (RF)23 (a non-linear model) has the potential to capture the non-linear relationships of cis-eQTLs and thus may improve gene expression imputation performance. Most recently, a method called TIGAR,19 which is based on a non-parametric Bayesian method called Dirichlet process regression,24 was shown to achieve a better imputation coefficient of determination (R2) than PrediXcan on simulation data where at least 1% of the cis-eQTLs are causal and true expression heritability is at most 0.2. TIGAR19 was also shown to impute expression for more genes than PrediXcan in a real dataset, thus corroborating the potential of using non-parametric and non-linear modeling of gene expression prediction in order to uncover more gene associations with complex traits.
Although several studies have shown that non-linear modeling of cis-eQTLs and gene expression can improve imputation performance,19,20,22 we sought to further explore the cross-population portability of both linear and non-linear transcriptome prediction in new cohorts. Generally, a large UK Biobank-based study has shown reduced accuracy in genetic prediction due to lack of diversity in training cohorts.25 More specifically, the importance of genetic ancestry diversity in gene expression prediction has also been corroborated by many recent studies, which have demonstrated that similarity in ancestries between the training and testing populations improves gene expression prediction.26–29 However, the replicability of these observations in new cohorts and how machine learning (ML) models perform across populations have not been adequately studied.
In this work, in order to further optimize gene expression imputation performance across global populations, we used two non-linear ML models, RF23 and KNN;21 a combination of both linear and non-linear ML models, support vector regression (SVR);30 and a linear ML model, EN, to predict gene expression from genotypes of SNPs within 1 Mb of each gene. We trained prediction models using genotype and blood monocyte transcriptome data from the Multi-Ethnic Study of Atherosclerosis (MESA)26,31,32 in self-identified African Americans (AFA, n = 233), Hispanic Americans (HIS, n = 352), European Americans (CAU, n = 578), as well as the combined cohort (ALL, n = 1,163). We tested MESA model performance on new genotype and whole-blood transcriptome data from participants enrolled in the Modeling the Epidemiology Transition Study (METS), which includes Ghanaians and African Americans (n = 76).33,34 We compared the ML models and showed gene prediction models were generally best in EN, with RF having the closest parallel performance. We corroborated previous findings that similarity in ancestry improves gene expression prediction accuracy. When we applied the ML models to transcriptome-wide association studies (TWASs) of lipid traits in MESA, we showed that RF models detect associations missed by EN. By integrating other ML modeling into PrediXcan and diversifying training populations to include more global ancestries, we may uncover new genes associated with complex traits that have not been previously studied.
Material and methods
This study was approved by the Loyola University Chicago institutional review board (IRB) #210260091217 and Project #2014. Appropriate informed consent was obtained from human subjects.
Genomic and transcriptomic training data
MESA
The MESA cohort is made up of 6,814 individuals recruited from 6 sites across the United States (Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; northern Manhattan, NY; St. Paul, MN) and consists of 53% female and 47% male individuals between the ages of 45 and 84 years31 with the demographics approximately distributed as 38% CAU, 23% HIS, 28% AFA, and 11% Chinese American (CHN). From the whole cohort, RNA was extracted from CD14+ monocytes from 1,264 individuals across the three populations (AFA, HIS, CAU) and quantified on the Illumina Ref-8 BeadChip.32 Individuals with both genotype (dbGaP: phs000209.v13.p3) and expression data (GEO: GSE56045) included 234 AFA, 386 HIS, and 582 CAU. Illumina IDs were converted to Ensembl IDs using the RefSeq IDs from MESA and GENCODE35 version 18 (gtf and metadata files) to match Illumina IDs to Ensembl IDs. If there were multiple Illumina IDs corresponding to an Ensembl ID, the average of those values was used as the expression level.
MESA genotype data analysis and quality control
Genotype quality control and imputation were performed as previously described.26 To summarize, all MESA population genotypes were in genome build GRCh37/hg19. PLINK36 was used for quality control and cleaning of the genotype data. We removed SNPs with call rate < 99% or not in Hardy-Weinberg equilibrium (p < 0.00001), and linkage disequilibrium (LD) pruned the resulting SNPs by removing 1 SNP in a 50 SNP window if r2 > 0.3. We conducted identity by descent (IBD) analysis on the genotype data and removed one pair of related individuals (IBD > 0.05). The cleaned genotypes were merged with HapMAP populations (Yoruba in Ibadan, Nigeria [YRI]; Utah residents with Northern and Western European descent [CEU]; and East Asians from Beijing, China and Tokyo, Japan [ASN]), and principal component analysis was done both across and within populations using EIGENSTRAT.37 We used pre-LD-pruned variants and the Michigan Imputation Server and 1000 Genomes phase 3 v5 reference panel and Eagle v2.3 to impute genotypes in each of the MESA populations. The imputation reference populations were EUR for CAU and mixed population for AFA and HIS.38–40 Imputation results were first filtered by R2 < 0.8 and minor allele frequency (MAF) > 0.01, and ambiguous strand SNPs were removed. After filtering, 9,352,383 SNPs in AFA, 7,201,805 SNPs in HIS, and 5,559,636 SNPs in CAU were remaining for further analysis. After quality control, the final sample sizes used for the gene expression prediction model training are AFA = 233, HIS = 352, and CAU = 578. The final sample sizes used for downstream TWAS analysis are AFA = 1,188, HIS = 952, and CAU = 1,716.
MESA transcriptome data analysis and quality control
PEER factor (PF) analysis was performed on the expression data of each population using the peer R package.41 Mogil et al.26 showed that the true positive replication rate was similar for 10, 20, and 30 PEER factors. As such, in each of the MESA populations, we used 10 peer factors and 3 genotype principal components (Figure S1) to adjust for potential batch effects and experimental confounders in the measured gene expression data. Then, we quantile normalized adjusted expression levels for use in model building.
Genomic and transcriptomic test data
METS
The METS cohort comprises 2,506 healthy individuals of African origin between the ages of 25 to 45 years, with approximately 500 (~50% male) from each of the five sites: Ghana; South Africa; Seychelles; Jamaica; and Chicago, IL, USA.42 Out of this cohort, 76 female individuals (37 Ghana and 39 Chicago, IL, USA) underwent genome-wide genotyping on the Illumina Infinium Multi-Ethnic AMR/AFR BeadChip and RNA sequencing (RNA-seq) from whole blood using the NuGEN mRNA-Seq with AnyDeplete Globin library preparation kit (Loyola IRB #210260091217). Single-end 50 bp RNA-seq was performed by the Duke University Sequencing and Genomic Technologies Shared Resource.
METS genotype data analysis and quality control
The METS genotype data are in genome build GRCh38/hg38. We performed all quality control using PLINK v1.90b4.4.36 We removed SNPs on non-autosomal chromosomes, below a call rate threshold of 0.01, or not in Hardy-Weinberg equilibrium (p < 0.00001). Prior to IBD and principal component analysis, we LD-pruned variants using PLINK indep-pairwise option at thresholds 50 5 0.3. Due to small sample size, we did not remove individuals based on cryptic relatedness. As such, we inferred the relationships of all pairs of individuals in our sample using KING43 package version 2.2.5. To account for the cryptic relatedness, we used the relationship inference from KING43 to calculate principal components (Figure S1) using the PC-Air44 tool in GENESIS45 package version 2.16.1. We performed METS genotype imputation on the Sanger Imputation service40,46 using the African Genome Resources reference panel and the pre-LD-pruned set of variants. After imputation, non-ambiguous strand SNPs in Hardy-Weinberg equilibrium (p > 0.05) with MAF > 0.05 and imputation R2 > 0.8 were retained, and the cleaned genotypes were lifted over to genome build GRCh37/hg19 for gene expression prediction analyses.
METS transcriptome data analysis and quality control
We used FASTQC47 to analyze RNA-seq quality and found 50 high-fidelity bases with no primers or over-represented sequences. We quantified gene expression using Salmon pseudoalignment,48 which estimates the transcripts per million (TPM) for each gene using a reference transcriptome without performing the time-consuming process of an actual alignment. We used only protein-coding genes as defined by GENCODE35 version 28 and removed genes with mean TPM < 0.01. The resulting expression data of all samples were quantile and rank normalized. We further adjusted for potential batch effects, experimental confounders, and population structure on all the sample expression levels with 10 PEER factors41 and 10 genotypic principal components (Figure S1). The resulting adjusted expression levels were used in downstream analysis.
Prediction models
In each of the MESA populations, we used the adjusted expression values for protein-coding genes and genotypes of SNPs within 1 Mb of each gene (i.e., in cis) to fit the models. Using nested cross-validation for EN, and 5-fold cross-validation for the other ML models, we calculate the R2 for how the model predicts on the held-out fold. We report the mean R2 over all 5 folds as our measure of model performance. R2 is defined as where yo is observed expression, yp is predicted expression, and is the mean of observed expression. Note that in this paper, R2 is not the square of the Pearson correlation coefficient. Instead, the coefficient of determination, R2 as defined above, can be negative and thus indicative of a poorly fit model. We used the fitted model to predict expression in METS. Model performance was evaluated by Spearman correlation (ρ) of the METS predicted and observed gene expression values defined by GENCODE35 version 28. Like prior studies, we considered ρ > 0.1 as significant.11,26 In our TWAS application of these models, we used the Bonferroni correction for the total number of genes tested across all four ML models (0.05/[5,279 + 3,651 + 3,772 + 2,601]) and thus considered (p < 3.3 × 10−6) to be significant.
EN
We used the glmnet R package49 to implement EN with the alpha parameter set at 0.5, which has previously been shown to perform optimally for predicting gene expression.10 Alpha is the mixing parameter of EN used to achieve the combination effect of lasso (alpha = 1) and ridge (alpha = 0) penalties. For every single gene, we carried out nested cross-validation of the EN model as follows: first, training data were split into roughly five equal parts; second, for each held-out fold, 10-fold cross-validation was performed on the remaining four folds to minimize the lambda parameter, and the model with the minimal lambda was used to predict on the held-out fold to determine the R2. Lambda is a tuning parameter that controls the overall strength of the EN penalty in each gene model. After going through each of the five folds, we used the average R2 as our measure of model performance. The trained models with minimal lambda were used to predict expression in the test data.26
RF
We used the scikit-learn Python package version 0.21.250 (Python version 3.7.3) to implement RF regression, and all the hyperparameters in the regressor were set to default except for the n_estimators hyperparameter (which is the number of trees in the forest). For every single gene, via 5-fold cross-validation, we conducted a grid search of the best n_estimators hyperparameter ranging from 50 to 500, inclusive, that yields the highest cross-validated regression R2. The range of trees used in the grid search was informed by our preliminary analysis result as shown in Figure S2. Subsequently, for every gene, we used the resulting best n_estimators hyperparameter to fit the RF regressor model and predict expression in the test data. See Table S1 for the optimum number of trees for each gene across training populations.
KNN
We used the scikit-learn Python package version 0.21.250 (Python version 3.7.3) to implement KNN regression. The hyperparameters were set to default except for n_neighbors (which is the number of neighbors [k] to use), weights (which is a weight function used in the prediction), and P (which is the power parameter for the Minkowski metric). We used two of the weights function parameters, namely “uniform” (wherein all points in each neighborhood are weighted equally) and “distance” (wherein all points in each neighborhood are weighted by the inverse of their distance). For every gene, via 5-fold cross-validation, we conducted a grid search of the best three hyperparameter combinations that yield the highest cross-validated regression R2. The three hyperparameter combinations were drawn from k (odd numbers between 3 and 31 inclusive), weights (uniform and distance), and P (1, 2, 3). Subsequently, for every gene, we used the resulting best hyperparameter combination to fit the KNN regressor model and predict expression in test data. See Table S2 for the optimum hyperparameter combinations for each gene across training populations.
SVR
We used the scikit-learn Python package version 0.21.250 (Python version 3.7.3) to implement SVR. We set all parameters to default except for the followings: gamma (controls the bias-variance trade-off of each gene model, where small values mean far-reaching radius of influence while large values mean close radius of influence. We set it to “scale” because we want the gamma value to be determined by the variance and number of predictors in each gene model), kernel (which is the type of mathematical function used to transform data in the model), degree (which is specifically for the degree of the polynomial kernel function), and C (which is the penalty for error term). For every gene, via 5-fold cross-validation, we conducted a grid search of the best three hyperparameter combinations that yield the highest cross-validated regression R2. The three hyperparameter combinations were drawn from kernel (“linear,” “poly,” “rbf,” “sigmoid”), degree (2, 3, 4, 5, 6, 7), and C (0.0001, 0.0005, 0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 1.0, 1.5, 2.0). Specifically, the kernels are divided into two groups: linear kernels, which includes only “linear,” and non-linear kernels which include “poly,” “rbf,” and “sigmoid.” Thus, the kernel used determines if the SVR model is a linear or non-linear model. Subsequently, for every gene, we used the resulting best hyperparameter combination to fit the SVR regressor model and predict expression in test data. The number of gene models with R2 > 0.01 built with different kernels is distributed as follows: AFA = 340, 1,243, 501, 564; CAU = 1,065, 1,269, 577, 476; HIS = 595, 1,210, 608, 643; ALL = 1,600, 1,288, 653, 231; for “linear,” “poly,” “rbf,” and “sigmoid” kernels, respectively. See Table S3 for the optimum hyperparameter combinations for each gene across training populations.
Model standardization
In addition to our user-defined grid searches described above, we also compared predictive performance among all the four ML models by implementing them in the same package with standardized hyperparameter tuning. We implemented all the tested ML models (EN, RF, SVR, and KNN) with scikit-learn Python package version 0.21.250 (Python version 3.7.3) and used Hyperopt51 version 0.2.4 to standardize the hyperparameter tuning across the ML methods. Specifically, we fixed the maximum number of evaluations (max_evals = 30) for the ML models. The choice of setting the maximum evaluations to thirty is to reduce computational time, especially for RF, which takes a longer time to run. Thus, for EN versus KNN, and EN versus SVR, like in grid search above, we built models for all protein-coding genes in chromosomes 1–22, while for EN versus RF, we focused only on chromosome 22. See Figure S3 for the model comparisons.
Results
EN outperforms ML models for cross-validated gene expression prediction
We sought to determine if untested ML models could improve SNP-based imputation of the transcriptome across populations compared to the parametric EN models currently used in PrediXcan.11 We trained each of the ML algorithms—RF, SVR, and KNN—using genotype and blood monocyte transcriptome data from each population in the MESA. The training samples in the MESA populations are distributed as AFA (n = 233), CAU (n = 578), and HIS (n = 352). To have a larger sample size, we also combined the genotype and transcriptome of the MESA populations (AFA, HIS, CAU) into the ALL cohort (n = 1,163). Standard quality control analysis was done on the genotype and expression data to adjust for population structure and potential experimental confounders (see Material and methods). Using each of the MESA populations and ALL, we then performed model training through 5-fold cross validation of RF, SVR, and KNN and nested cross-validation of EN by using SNPs within 1 Mb of each gene to predict its expression level. We used the R2 between predicted and observed expression as our measure of model performance (see Material and methods). We found that across all the populations and prediction algorithms, ERAP2 (MIM: 609497), HLA-C (MIM: 142840), HLA-DRB1 (MIM: 142857), CHURC1 (MIM: 608577), RAD51 (MIM: 179617), and SNAP29 (MIM: 604202) have R2 > 0.5. We also found that EN usually outperformed the ML models, but RF outperformed EN on some gene models, especially those trained in HIS and CAU (Figures 1 and S4). This suggests that different prediction algorithms may be potentially more robust for different training populations.
To better ensure our comparison of the four ML models was not affected by our chosen software packages and grid search spaces, we also compared standardized models using Hyperopt51 (see Material and methods). Hyperopt is a Python library that standardizes model selection and hyperparameter optimization.51 Gene expression prediction model performance obtained from our implementation of the Hyperopt51 standardization approach maintained the same trend of EN outperforming the other three tested ML models (Figure S3). Thus, we use our grid search optimization approach in the ML model results described in the rest of this paper.
Focusing only on the model training built in the ALL cohort, the model building converged and completed for 9,623 genes in RF, SVR, and KNN and 9,622 in EN. The 9,622 genes in EN models are also in SVR and KNN, while 9,621 are in RF. The average R2 for each of the prediction algorithms is EN = 0.0733, SVR = 0.0476, RF = 0.0409, and KNN = 0.0103. TACSTD2, RNF150, HLA-DRB5, HLA-DRB1, and CHURC1 genes have R2 > 0.8 across EN, RF, and SVR models, while all genes in the KNN model have R2 < 0.8. Overall, EN significantly outperformed all ML models, as shown in Figure 1 and Table 1. Focusing on the overlapping genes with R2 > 0.01 (EN versus SVR = 3,736, EN versus RF = 3,635, EN versus KNN = 2,598), EN performed better on approximately 99%, 97%, and 93% of the overlapping genes than KNN, SVR, and RF, respectively. Table 2 shows the number of genes that have models in each of the prediction algorithms at different R2 thresholds. EN had the most gene models compared to the other ML methods across all thresholds. However, at R2 > 0.5, RF has almost same number of gene models as EN (RF = 194, EN = 222), distantly followed by SVR, while KNN has just 28 genes. This clearly shows that EN, RF, and SVR models have generally good performance for most of the highly predictable genes. The same comparison trend is generally observed in the models trained with AFA, CAU, and HIS (Tables S4–S6). However, while mean predictive performance was higher for EN across populations (Table 1), we observed that RF outperformed EN for some genes, especially in HIS- and CAU-trained data (Figure 1). This suggests integrating both EN and RF models into transcriptome prediction may be useful. Next, we sought to determine how our models performed in an independent test cohort.
Table 1.
Population | EN | RF | SVR | KNN |
---|---|---|---|---|
AFA | 0.0528 | 0.0041 | 0.0120 | −0.0086 |
HIS | 0.0479 | 0.0156 | 0.0289 | 0.0001 |
CAU | 0.0596 | 0.0283 | 0.0437 | 0.0094 |
ALL | 0.0733 | 0.0409 | 0.0476 | 0.0103 |
Elastic net (EN) had higher mean performance than each of the other machine learning models across the MESA populations (all paired t test p values < 4 × 10−19). AFA, MESA African American; CAU, MESA European American; HIS, MESA Hispanic American; ALL, all MESA; RF, random forest; SVR, support vector regression; KNN, K nearest neighbor.
Table 2.
Method | R2 > −0.1 | R2 > −0.01 | R2 > 0 | R2 > 0.01 | R2 > 0.05 | R2 > 0.1 | R2 > 0.5 |
---|---|---|---|---|---|---|---|
EN | 9,622 | 9,621 | 6,823 | 5,729 | 3,176 | 2,108 | 222 |
RF | 9,544 | 4,924 | 4,158 | 3,651 | 2,449 | 1,687 | 194 |
SVR | 9,622 | 8,929 | 5,355 | 3,772 | 2,185 | 1,454 | 141 |
KNN | 9,263 | 4,193 | 3,206 | 2,601 | 1,422 | 839 | 28 |
Total gene models before filtering; EN = 9,622, RF = 9,623, SVR = 9,623, KNN = 9,623. EN, elastic net; RF, random forest; SVR, support vector regression; KNN, K nearest neighbor.
Similarity in ancestry improves prediction performance across prediction models
Recent studies using EN have observed that similarity in training and testing population improves prediction performance.26–29 In order to see if the same observation replicated with additional ML algorithms, we used new genotype and whole-blood transcriptome data from 76 African American individuals in Chicago, Illinois (USA) and Africans in Ghana enrolled in METS as a replication cohort.34,42 We performed standard quality control and adjusted for potential confounders in the METS genotype and transcriptome data (see Material and methods). We predicted gene expression in the METS cohort using only gene models with cross-validated R2 > 0.01 in each of the prediction algorithms trained with the MESA cohort. Specifically, we tested models trained in each of the MESA populations (AFA = 233, HIS = 352, CAU = 578) and the combined population (ALL = 1,163). To accommodate for any effect sample size may have in our study, we also used the combination of AFA and HIS populations (AFHI = 585), which is a similar sample size as CAU, to train the prediction algorithms. Both AFA and HIS contain recent African admixture and thus share more genetic ancestries with our test cohort (METS) than CAU (Figure S5). To determine how accurate the prediction algorithms trained in MESA are in METS, we computed the Spearman correlation (ρ) between the METS predicted expression values and METS measured expression values.
To evaluate the prediction performance of the training MESA population in METS, for each of the prediction algorithm methods, we calculated the mean ρ for genes predicted in all 5 of the populations (Table 3). Across the training populations, the mean ρ in METS is highest when using AFHI-trained models for all the prediction algorithms. As shown in Table 3, across all the tested prediction algorithms, the training populations comprising individuals of recent African ancestries (AFA, HIS, AFHI, ALL) significantly outperformed the training population comprising only individuals of European descent (CAU) (Welch’s t test, all algorithm p values < 0.0210, except for KNN, where HIS versus CAU p value = 0.1226). This shows that prediction performance is highest when the genetic distance between the training population and testing population are closest, regardless of the prediction algorithm used. Also, larger sample size improves prediction performance but not as much as when majority of the individuals in the training set share similar ancestries with those in the test set (i.e., AFHI-trained models perform the same as ALL-trained models) (Welch’s t test, all algorithm p values > 0.6360) (Table 3). If larger sample size were the main factor to improve prediction performance, we would expect the average ρ to be significantly higher in ALL. However, we see that average ρ in the ALL is less than in the AFHI, even though AFHI has lower sample size. More so, the ALL-trained models’ average ρ were not significantly better than AFA-trained models (Welch’s t test p values, EN = 0.5053, RF = 0.3782, SVR = 0.0424, KNN = 0.5391). AFA has the lowest sample size and closest ancestry similarity to METS across the training MESA populations. Thus, this highlights the importance of similarity in ancestry at improving prediction performance.
Table 3.
Model | AFA | HIS | CAU | AFHI | ALL | Number of genes |
---|---|---|---|---|---|---|
EN | 0.1123 | 0.0859 | 0.0674 | 0.1211 | 0.1185 | 2,097 |
RF | 0.1217 | 0.1163 | 0.0931 | 0.1272 | 0.1265 | 1,574 |
SVR | 0.1015 | 0.1005 | 0.0857 | 0.1144 | 0.1142 | 1,415 |
KNN | 0.0854 | 0.0784 | 0.0684 | 0.0897 | 0.0899 | 1,069 |
We focused on the genes predicted in all 5 of the training populations for each prediction method. EN, elastic net; RF, random forest; SVR, support vector regression; KNN, K nearest neighbor; AFA, MESA African American; HIS, MESA Hispanic American; CAU, MESA European American; AFHI, MESA African American and Hispanic American; ALL, all MESA.
When we examine all prediction results in METS, the number of genes we were able to predict gene expression values for varied across algorithms and populations (Figure 2). The gene models trained with the ALL cohort predicted gene expression values for more genes than the other training populations across all prediction algorithms. This is probably because the ALL cohort had the largest sample size. In fact, the number of genes captured decreases from ALL to AFA as the sample size decreases, with the exception of EN trained on HIS. Interestingly though, when we filter by ρ > 0.1, EN trained on AFA captures more genes (1,622) than HIS (1,238) and CAU (1,238), while RF trained on HIS (1,219) and AFA (1,190) each capture more genes than CAU (1,078), despite CAU having a larger sample size than AFA and HIS. This again shows the importance of similarity in ancestry between training and testing population for gene expression prediction. The models trained with AFHI and ALL cohorts capture more genes than AFA, most probably because of their larger sample size and the fact that they also contain the AFA cohort. Therefore, although larger sample size is important in prediction performance, it is paramount that individuals in the training population have similar ancestry with the testing population.
EN-trained models outperform ML models in test cohort
EN predicts gene expression values in METS for more genes than RF, SVR, and KNN (Figure 2). When all genes predicted in METS by all 4 of the prediction algorithms for each training population are compared, mean prediction performance (ρ) is significantly highest for RF-trained models in the HIS and CAU populations, while mean prediction performance is highest for EN-trained models in the AFA, AFHI, and ALL populations (Figure 3; Table 4). Furthermore, when we compare test prediction performance of each of the ML algorithms against EN on the genes they both can predict (intersection) for each training population, EN performs best regardless of training population except in HIS and CAU, where mean prediction performance was again better in RF than EN (Figures 4 and S6; Table 5). Focusing only on ALL-trained models, the number of overlapping genes between EN and the other algorithms are RF = 1,198, SVR = 1,141, and KNN = 676.
Table 4.
Population | EN | RF | SVR | KNN | Number of genes |
---|---|---|---|---|---|
AFA | 0.1210 | 0.1150 (p = 3.0 × 10−3) | 0.0959 (p = 4.5 × 10−23) | 0.0723 (p = 1.9 × 10−47) | 1,640 |
HIS | 0.0880 | 0.1066 (p = 5.3 × 10−11) | 0.0896 (p = 5.9 × 10−1) | 0.0648 (p = 1.4 × 10−12) | 1,809 |
CAU | 0.0620 | 0.0770 (p = 1.3 × 10−7) | 0.0699 (p = 4.0 × 10−3) | 0.0475 (p = 5.4 × 10−6) | 2,091 |
AFHI | 0.1111 | 0.1068 (p = 1.1 × 10−2) | 0.0944 (p = 8.8 × 10−16) | 0.0695 (p = 9.6 × 10−50) | 2,290 |
ALL | 0.1074 | 0.1046 (p = 1.2 × 10−1) | 0.0944 (p = 1.3 × 10−11) | 0.0659 (p = 9.0 × 10−49) | 2,315 |
For each training population, we took only intersection genes predicted by EN, RF, SVR, and KNN. Focusing on these intersects for each training population, we calculated the mean prediction performance (ρ). The paired t test p value between EN and each other model is shown in parentheses. EN, elastic net; RF, random forest; SVR, support vector regression; KNN, K nearest neighbor; AFA, MESA African American; HIS, MESA Hispanic American; CAU, MESA European American; AFHI, MESA African American and Hispanic American; ALL, all MESA.
Table 5.
Population | EN versus RF | EN versus SVR | EN versus KNN |
---|---|---|---|
AFA | 0.1075 versus 0.1021 (p = 2.8 × 10−3) | 0.1072 versus 0.0857 (p = 2.2 × 10−20) | 0.1111 versus 0.0691 (p = 6.4 × 10−6) |
HIS | 0.0793 versus 0.0960 (p = 2.1 × 10−11) | 0.0797 versus 0.0799 (p = 0.95) | 0.0846 versus 0.0616 (p = 1.8 × 10−13) |
CAU | 0.0555 versus 0.0699 (p = 1.1 × 10−8) | 0.0535 versus 0.0588 (p = 0.024) | 0.0592 versus 0.0450 (p = 3.7 × 10−6) |
AFHI | 0.0991 versus 0.0924 (p = 8.7 × 10−6) | 0.0975 versus 0.0815 (p = 9.9 × 10−19) | 0.1058 versus 0.0661 (p = 1.7 × 10−49) |
ALL | 0.0909 versus 0.0871 (p = 0.017) | 0.0902 versus 0.0774 (p = 2.8 × 10−14) | 0.1041 versus 0.0628 (p = 1.5 × 10−50) |
We performed paired t tests between the prediction performance of EN and each of the other machine learning models with each training population. The t test p values are shown in parentheses. EN, elastic net; RF, random forest; SVR, support vector regression; KNN, K nearest neighbor; AFA, MESA African American; HIS, MESA Hispanic American; CAU, MESA European American; AFHI, MESA African American and Hispanic American; ALL, all MESA.
Although generally EN outperforms the other algorithms, we observe that all the genes in each of the algorithms did not overlap with those in EN even though they captured fewer genes than EN (Table 6). That is, these algorithms have significant performance (ρ > 0.1) on some genes that EN does not, and vice versa. To probe further into the algorithm pairs, we counted the genes unique to each algorithm (Table 6). Expectedly, EN captures 778 unique genes; however, the few unique genes (<310) captured by each of RF, SVR, and KNN suggest that prediction performance in test cohorts may be improved by combining gene models from EN and these other algorithms. Focusing only on the RF and EN sets of unique genes, we found that the average normalized expression levels were slightly higher in the RF group (mean = 0.0318) than the EN group (mean = 0.0291) (Welch’s t test p value = 0.0014). Additionally, the average variance in the normalized expression levels was slightly higher in the RF group (0.678) than the EN group (0.639) (Welch’s t test p value = 0.019). Since the magnitude of these differences is not large, it is unlikely variation in the expression levels is the reason these genes are captured only by the RF algorithm. Moreover, model performance and, by extension, ability to capture unique genes is not driven by or correlated with expression levels (Figures S7 and S8). In addition, upon performing principal component analysis of expression levels, we found that the genes did not cluster by prediction algorithm (Figure S9).
Table 6.
Genes | EN versus RF | EN versus SVR | EN versus KNN | |||
---|---|---|---|---|---|---|
Overlap | 1,198 | 1,141 | 676 | |||
Unique | 778 | 309 | 835 | 309 | 1,300 | 233 |
We only counted genes where the algorithms have significant performance (ρ > 0.1). EN, elastic net; RF, random forest; SVR, support vector regression; KNN, K nearest neighbor.
EN and ML models identify the same gene in lipid TWASs
To evaluate the biological importance of the prediction algorithms in identifying significant genes associated with traits, we carried out TWASs on high-density lipoprotein (HDL) levels. In our analysis, we used a genotype dataset from the MESA cohort (n = 3,856), comprising individuals from the populations that were not used in building any of the imputation models and in which we have corresponding lipid phenotype data (AFA = 1,188, HIS = 952, and CAU = 1,716). The genotype data were cleaned using standard quality-control procedures (see Material and methods). We used the ALL-trained imputation gene models (genes with cross-validated R2 > 0.01) from each algorithm to impute transcriptome levels from the MESA genotypes. We adjusted the predicted transcriptome levels for population structure using the first 3 genotype principal components (Figure S1) and rank normalized the HDL levels. Using the adjusted predicted transcriptome levels and normalized HDL data, we conducted association tests using linear regression. Interestingly, all tested prediction algorithms except KNN identified a significant association (p < 3.3 × 10−6) for the cholesteryl ester transfer protein, plasma gene (CETP [MIM: 118470]) (Figures 5 and S10). The lack of association with HDL for all gene-expression values predicted from KNN-trained models is consistent with our earlier results in this paper that KNN is worse at imputing transcriptome levels compared to the other algorithms. The directions of effect of CETP transcriptome levels as predicted by EN, RF, and SVR are the same (Figure 6). An increase in predicted CETP expression is associated with decreased HDL levels across EN, RF, and SVR. The ability of the three algorithms to identify the same significant hit underscores their effectiveness at imputing gene expression (CETP R2: EN = 0.0917, RF = 0.0772, SVR = 0.0539). Consequently, wecompared EN and RF t-statistic values from the association tests between HDL and predicted gene expression. We found that both EN and RF t-statistic values were almost parallel for the genes they have in common, thus corroborating the observed similar performance on their common genes from our previous results (Figures 1 and 3). In the EN TWAS, 5,279 genes were tested for association with HDL. In the RF TWAS, 16 unique genes that were not present in the EN TWAS were tested for association with HDL (Figure 7). Among the RF unique genes, we found a potential gene, ST8SIA4 (MIM: 602547), that may be associated with normalized HDL (p = 3.192 × 10−3) but was missed by EN (ST8SIA4 R2: EN = −0.0005, RF = 0.0100) (Figure 7). Although the association did not pass the Bonferroni correction to be genome-wide significant, this discovery is consistent with our previous results, wherein we found that although EN has many genes in common with RF in their imputation models, the RF algorithm generated some unique gene models (Table 6). Thus, by combining EN and RF models in gene expression imputation and subsequent TWAS analysis, we may uncover more and new significant gene-trait associations. Note, however, that by combining EN and RF models, we are not significantly changing the number of tests performed. Depending on predictive performance inclusion threshold, adding RF expression prediction models may increase the number of tests by up to 16% (Table 6), which does not dramatically change the Bonferroni correction threshold.
Discussion
In this paper, we explored the potential of using RF, SVR, and KNN to further improve gene expression prediction performance across global populations in comparison to EN modeling, which is currently used in PrediXcan.11 To accomplish this, we trained each of the prediction models with genotype and transcriptome data from the MESA cohort on 9,623 protein-coding genes and compared their cross-validated imputation performance (R2). Although almost paralleled by RF and SVR, we found EN generally outperformed the other tested ML models. This is consistent with a recent study where it was shown that the genome-wide polygenic risk score method based on simple linear additive effects of genetic factors outperformed ML models in genetic prediction of cardiovascular disease risk.52 However, in our study, we found that when the prediction models are trained within each of the MESA populations, RF sometimes outperformed EN, specifically on HIS and CAU data (Figures 1 and 3; Tables 1 and 4). This suggests potential robustness and reduced variability of RF imputation performance across global populations.
We further tested the MESA-trained models on genotype and transcriptome data from African-origin individuals in the METS cohort. We show that models trained with the cohorts (AFA, HIS, AFHI, ALL) comprising individuals similar in ancestries with METS have better prediction performance than the models trained with individuals (CAU) of no recent African ancestries (Table 3; Figure 3). Thus, as demonstrated in several recent studies,26–29 here we also show similarity in ancestries between training and testing populations improves prediction performance. Notably, we found that the improvement in prediction due to ancestry similarity is consistent within all tested prediction algorithms, further underscoring the huge importance of diverse ancestries in genetic studies.
In the application of the MESA-trained models to the METS cohort, we further compared the prediction performance of EN against the other ML models. Although EN consistently outperformed the other tested models (which further corroborates the cross-validated performance results), we found gene models that are unique to each prediction algorithm (Table 6). Further analysis suggests there is nothing strikingly unusual in the expression levels of these groups of genes (Figures S7–S9). Therefore, it is unlikely variation in the expression levels is the reason these genes are captured only by one algorithm over another.
We applied the trained models on out-of-sample MESA genotype data with corresponding HDL phenotype values. All tested prediction models except for KNN identified the gene CETP to be significantly associated with HDL. As seen in a recent study on lipid traits,53 we show that increased CETP expression is significantly associated with lower HDL levels, and the direction of effect is the same for EN, RF, and SVR models. Thus, we computationally corroborate the biological importance of CETP gene in HDL-associated diseases. In many studies, the CETP gene has been experimentally associated with HDL levels in humans, and it currently stands as a potential drug target for the treatment of atherosclerosis.54–58 Thus, our analysis in a relatively small TWAS (n = 3,856) identified a known drug target that has been studied extensively in the context of preventing cardiovascular disease.
Nonetheless, there are some limitations to the practical application of the non-linear ML models like RF in comparison to linear models like EN. One of the major flaws of ensemble tree regressions such as RF is that they cannot extrapolate to data points (or ranges) they have not seen, thus restricting predictive performance of each RF model to the boundaries of the training dataset. Unlike RF, linear models such as EN and SVR with linear kernel can generate prediction values for data points beyond the boundaries of the training data because they can extrapolate well. Additionally, EN models typically expose the predictors and their corresponding effect sizes such that they are easily accessible and extractable, while RF models do not. Access and utilization of these predictors and effect sizes can make application on test datasets much easier and relatively faster. Another practical consideration is the ability of the prediction models to utilize GWAS summary statistics as input data instead of the actual genotype dataset. This is important because of the data-sharing limitations often associated with human genetic information. EN as implemented in S-PrediXcan59 is able to predict gene expression with only the GWAS summary statistics, while the applicability of non-linear models like RF in TWASs is limited to only GWASs with genotype and phenotype data available. As such, EN has more practical advantage than RF for genes that both algorithms can predict.
We also note that improvements in expression prediction performance beyond EN have recently been demonstrated by integrating adaptive shrinkage methods like MASHR, which improves effect size estimates across multiple experiments.60 Applying MASHR worked well in the context of using GTEx Project data to build gene expression prediction models because of similar eQTL effect sizes across the 54 tissues of GTEx.61 There might be a role for a MASHR-like framework to build cross-population models in either the same or multiple tissues, and this is a promising avenue for future research when more diverse population transcriptome data are available.
In conclusion, although linear modeling of SNPs and gene expression is generally good at imputing expression for new data, linear models may fail to accurately predict expression for some genes. Interestingly, our study shows the imputation performances for some genes are comparatively better with non-linear ML models like RF (Figure 4) than linear models like EN, especially between diverse populations. Therefore, by increasing ancestry diversity and sample sizes of study populations, optimizing prediction performance on these genes with RF modeling may be warranted. While incorporating RF models into the existing PrediXcan tool has practical limitations, doing so may be justified when genotypes are available to increase the probability of uncovering new gene-trait associations in downstream transcriptome-phenotype analyses.
Supplementary Material
Acknowledgments
This work is supported by the NIH National Human Genome Research Institute Academic Research Enhancement Award R15 HG009569 (H.E.W.), Loyola University Chicago Bioinformatics Fellowship (P.C.O.), Loyola Strategic Plan 2020 Health-EQ Award (H.E.W. and L.R.D.), and R01 MH107666 (H.K.I.). MESA and the MESA SHARe projects are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N9202 0D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420; the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881; and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Genotyping was performed at Affymetrix (Santa Clara, CA, USA) and the Broad Institute of Harvard and MIT (Boston, MA, USA) using the Affymetrix Genome-Wide Human SNP Array 6.0. The MESA Epigenomics & Transcriptomics Study was funded by NIA grant 1R01HL101250-01 to Wake Forest University Health Sciences (Y.L.). We thank the Duke University School of Medicine for the use of the Sequencing and Genomic Technologies Shared Resource, which performed METS RNA-Sequencing, and The University of Chicago Genomics Facility, which performed METS genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Footnotes
Data and code availability
All the scripts used and models built in this study are freely available at GitHub: WheelerLab/ML-PredictDB. MESA genotype data are available at dbGaP (dbGaP: phs000209.v13.p3) and MESA expression data at GEO (GEO: GSE56045). 1000 Genomes genotype data are available at the IGSR website. There are restrictions to the availability of METS genotype and phenotype data due to data-sharing limitations of the IRB-approved informed consent (Loyola IRB #210260091217).
Supplemental information
Supplemental Information can be found online at https://doi.org/10.1016/j.xhgg.2020.100019.
Declaration of interests
The authors declare no competing interests.
References
- 1.Visscher PM, Brown MA, McCarthy MI, and Yang J (2012). Five years of GWAS discovery. Am. J. Hum. Genet 90, 7–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H, McMahon A, Milano A, Morales J, et al. (2017). The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 45 (D1), D896–D901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JPA, and Hirschhorn JN (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet 9, 356–369. [DOI] [PubMed] [Google Scholar]
- 4.Huang Q (2015). Genetic study of complex diseases in the post-GWAS era. J. Genet. Genomics 42, 87–98. [DOI] [PubMed] [Google Scholar]
- 5.Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, and Cox NJ (2010). Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6, e1000888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Gamazon ER, Huang RS, Cox NJ, and Dolan ME (2010). Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc. Natl. Acad. Sci. USA 107, 9287–9292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gamazon ER, Im HK, Liu C, Nicolae DL, Cox NJ, Nicolae DL, and Cox NJ; BiGS Consortium. (2013). The convergence of eQTL mapping, heritability estimation and polygenic modeling: emerging spectrum of risk variation in bipolar disorder. arXiv, 1303.6227. [Google Scholar]
- 8.Battle A, Brown CD, Engelhardt BE, and Montgomery SB; GTEx Consortium; Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group; Statistical Methods groups—Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Common Fund; NIH/NCI; et al. (2017). Genetic effects on gene expression across human tissues. Nature 550, 204–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gamazon ER, Segrè AV, van de Bunt M, Wen X, Xi HS, Hormozdiari F, Ongen H, Konkashbaev A, Derks EM, Aguet F, et al. ; GTEx Consortium (2018). Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat. Genet 50, 956–967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wheeler HE, Shah KP, Brenner J, Garcia T, Aquino-Michaels K, Cox NJ, Nicolae DL, Im HK; and GTEx Consortium (2016). Survey of the heritability and sparse architecture of gene expression traits across human tissues. PLoS Genet. 12, e1006423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gamazon ER, Wheeler HE, Shah KP, Mozaffari SV, Aquino-Michaels K, Carroll RJ, Eyler AE, Denny JC, Nicolae DL, Cox NJ, Im HK; and GTEx Consortium (2015). A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet 47, 1091–1098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BWJH, Jansen R, de Geus EJC, Boomsma DI, Wright FA, et al. (2016). Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet 48, 245–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zou H, and Hastie T (2005). Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B. Stat. Methodol 67, 301–320. [Google Scholar]
- 14.Zhou X, Carbonetto P, and Stephens M (2013). Polygenic modeling with bayesian sparse linear mixed models. PLoS Genet. 9, e1003264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Tibshirani R (1996). Regression shrinkage and selection via the lasso. J. R. Stat. Soc. B 58, 267–288. [Google Scholar]
- 16.Hoerl AE, and Kennard RW (1970). Ridge regression: Biased estimation for nonorthogonal problems. Technometrics 12, 55–67. [Google Scholar]
- 17.Guan Y, and Stephens M (2011). Bayesian variable selection regression for genome-wide association studies and other large-scale problems. Ann. Appl. Stat 5, 1780–1815. [Google Scholar]
- 18.Yu J, Pressoir G, Briggs WH, Vroh Bi I, Yamasaki M, Doebley JF, McMullen MD, Gaut BS, Nielsen DM, Holland JB, et al. (2006). A unified mixed-model method for association mapping that accounts for multiple levels of relatedness. Nat. Genet 38, 203–208. [DOI] [PubMed] [Google Scholar]
- 19.Nagpal S, Meng X, Epstein MP, Tsoi LC, Patrick M, Gibson G, De Jager PL, Bennett DA, Wingo AP, Wingo TS, and Yang J (2019). Tigar: An improved bayesian tool for transcriptomic data imputation enhances gene mapping of complex traits. Am. J. Hum. Genet 105, 258–266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Manor O, and Segal E (2013). Robust prediction of expression differences among human individuals using only genotype information. PLoS Genet. 9, e1003396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cover T, and Hart P (1967). Nearest neighbor pattern classification. IEEE Trans. Inf. Theory 13, 21–27. [Google Scholar]
- 22.Wang J, Gamazon ER, Pierce BL, Stranger BE, Im HK, Gibbons RD, Cox NJ, Nicolae DL, and Chen LS (2016). Imputing gene expression in uncollected tissues within and beyond GTEx. Am. J. Hum. Genet 98, 697–708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Breiman L (2001). Random forests. Mach. Learn 45, 5–32. [Google Scholar]
- 24.Zeng P, and Zhou X (2017). Non-parametric genetic prediction of complex traits with latent Dirichlet process regression models. Nat. Commun 8, 456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Martin AR, Gignoux CR, Walters RK, Wojcik GL, Neale BM, Gravel S, Daly MJ, Bustamante CD, and Kenny EE (2017). Human demographic history impacts genetic risk prediction across diverse populations. Am. J. Hum. Genet 100, 635–649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Mogil LS, Andaleon A, Badalamenti A, Dickinson SP, Guo X, Rotter JI, Johnson WC, Im HK, Liu Y, and Wheeler HE (2018). Genetic architecture of gene expression traits across diverse populations. PLoS Genet. 14, e1007586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Mikhaylova AV, and Thornton TA (2019). Accuracy of gene expression prediction from genotype data with PrediXcan varies across and within continental populations. Front. Genet 10, 261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Keys KL, Mak ACY, White MJ, Eckalbar WL, Dahl AW, Mefford J, Mikhaylova AV, Contreras MG, Elhawary JR, Eng C, et al. (2020). On the cross-population generalizability of gene expression prediction models. PLoS Genet. 16, e1008927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Fryett JJ, Morris AP, and Cordell HJ (2020). Investigation of prediction accuracy and the impact of sample size, ancestry, and tissue in transcriptome-wide association studies. Genet. Epidemiol 44, 425–441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hearst MA, Dumais ST, Osuna E, Platt J, and Scholkopf B (1998). Support vector machines. IEEE Intelligence Systems and their Applications 13, 18–28. [Google Scholar]
- 31.Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr., Kronmal R, Liu K, et al. (2002). Multi-Ethnic Study of Atherosclerosis: objectives and design. Am. J. Epidemiol 156, 871–881. [DOI] [PubMed] [Google Scholar]
- 32.Liu Y, Ding J, Reynolds LM, Lohman K, Register TC, De La Fuente A, Howard TD, Hawkins GA, Cui W, Morris J, et al. (2013). Methylomics of gene expression in human monocytes. Hum. Mol. Genet 22, 5065–5074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Dugas LR, Forrester TE, Plange-Rhule J, Bovet P, Lambert EV, Durazo-Arvizu RA, Cao G, Cooper RS, Khatib R, Tonino L, et al. (2017). Cardiovascular risk status of Afro-origin populations across the spectrum of economic development: findings from the Modeling the Epidemiologic Transition Study. BMC Public Health 17, 438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Luke A, Bovet P, Plange-Rhule J, Forrester TE, Lambert EV, Schoeller DA, Dugas LR, Durazo-Arvizu RA, Shoham DA, Cao G, et al. (2014). A mixed ecologic-cohort comparison of physical activity & weight among young adults from five populations of African origin. BMC Public Health 14, 397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S, et al. (2012). GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760–1774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Chang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, and Lee JJ (2015). Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, and Reich D (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet 38, 904–909. [DOI] [PubMed] [Google Scholar]
- 38.Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, 1000 Genomes Project Consortium, et al. (2015). A global reference for human genetic variation. Nature 526, 68–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Das S, Forer L, Schönherr S, Sidore C, Locke AE, Kwong A, Vrieze SI, Chew EY, Levy S, McGue M, et al. (2016). Next-generation genotype imputation service and methods. Nat. Genet 48, 1284–1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Loh P-R, Danecek P, Palamara PF, Fuchsberger C, A Reshef Y, K Finucane H, Schoenherr S, Forer L, McCarthy S, Abecasis GR, et al. (2016). Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet 48, 1443–1448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Stegle O, Parts L, Piipari M, Winn J, and Durbin R (2012). Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat. Protoc 7, 500–507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Luke A, Bovet P, Forrester TE, Lambert EV, Plange-Rhule J, Schoeller DA, Dugas LR, Durazo-Arvizu RA, Shoham D, Cooper RS, et al. (2011). Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk. BMC Public Health 11, 927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, and Chen W-M (2010). Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867–2873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Conomos MP, Miller MB, and Thornton TA (2015). Robust inference of population structure for ancestry prediction and correction of stratification in the presence of relatedness. Genet. Epidemiol 39, 276–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Gogarten SM, Sofer T, Chen H, Yu C, Brody JA, Thornton TA, Rice KM, and Conomos MP (2019). Genetic association testing using the GENESIS R/Bioconductor package. Bioinformatics 35, 5346–5348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, Kang HM, Fuchsberger C, Danecek P, Sharp K, et al. ; Haplotype Reference Consortium (2016). A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet 48, 1279–1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Andrews S, Krueger F, Segonds-Pichon A, Biggins L, Krueger C, and Wingett S (2012). FastQC: a quality control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/. [Google Scholar]
- 48.Patro R, Duggal G, Love MI, Irizarry RA, and Kingsford C (2017). Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417–419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Friedman J, Hastie T, and Tibshirani R (2010). Regularization Paths for Generalized Linear Models via Coordinate Descent. J. Stat. Softw 33, 1–22. [PMC free article] [PubMed] [Google Scholar]
- 50.Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V, et al. (2011). Scikit-learn: Machine Learning in Python. J. Mach. Learn. Res 12, 2825–2830. [Google Scholar]
- 51.Bergstra J, Komer B, Eliasmith C, Yamins D, and Cox DD (2013). Hyperopt: a Python library for model selection and hyperparameter optimization. Comput Sci Discov 8, 014008. [Google Scholar]
- 52.Gola D, Erdmann J, Müller-Myhsok B, Schunkert H, and König IR (2020). Polygenic risk scores outperform machine learning methods in predicting coronary artery disease status. Genet. Epidemiol 44, 125–138. [DOI] [PubMed] [Google Scholar]
- 53.Andaleon A, Mogil LS, and Wheeler HE (2019). Genetically regulated gene expression underlies lipid traits in Hispanic cohorts. PLoS ONE 14, e0220827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Thompson JF, Lira ME, Durham LK, Clark RW, Bamberger MJ, and Milos PM (2003). Polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis 167, 195–204. [DOI] [PubMed] [Google Scholar]
- 55.Barter PJ, Brewer HB Jr., Chapman MJ, Hennekens CH, Rader DJ, and Tall AR (2003). Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler. Thromb. Vasc. Biol 23, 160–167. [DOI] [PubMed] [Google Scholar]
- 56.de Grooth GJ, Klerkx AHEM, Stroes ESG, Stalenhoef AFH, Kastelein JJP, and Kuivenhoven JA (2004). A review of CETP and its relation to atherosclerosis. J. Lipid Res 45, 1967–1974. [DOI] [PubMed] [Google Scholar]
- 57.Kosmas CE, Dejesus E, Rosario D, and Vittorio TJ (2016). CETP inhibition: past failures and future hopes. Clin. Med. Insights Cardiol 10, 37–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Tall AR, and Rader DJ (2018). Trials and tribulations of CETP inhibitors. Circ. Res 122, 106–112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Barbeira AN, Dickinson SP, Bonazzola R, Zheng J, Wheeler HE, Torres JM, Torstenson ES, Shah KP, Garcia T, Edwards TL, et al. ; GTEx Consortium (2018). Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun 9, 1825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Urbut SM, Wang G, Carbonetto P, and Stephens M (2019). Flexible statistical methods for estimating and testing effects in genomic studies with multiple conditions. Nat. Genet 51, 187–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Barbeira AN, Melia OJ, Liang Y, Bonazzola R, Wang G, Wheeler HE, Aguet F, Ardlie KG, Wen X, and Im HK (2020). Fine-mapping and QTL tissue-sharing information improves the reliability of causal gene identification. Genet. Epidemiol 44, 854–867. [DOI] [PMC free article] [PubMed] [Google Scholar]
Web resources
- 1000 Genomes, https://www.internationalgenome.org/
- Code, https://github.com/WheelerLab/ML-PredictDB
- dbGaP, https://www.ncbi.nlm.nih.gov/gap/
- GEO, https://www.ncbi.nlm.nih.gov/geo/
- OMIM, https://www.omim.org/
- PLINK, https://www.cog-genomics.org/plink2
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.